Best Life Sciences Companies in Wisconsin, United States
The 205 best Life Sciences companies in Wisconsin, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Exact Sciences.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Wisconsin
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Exact Sciences Provider of non-invasive molecular diagnostic testing solutions for cancer | $1.9B | 87 mo ago | 6,600 6,600 → 5,319 (-19%) | Kevin Conroy Chairman & CEO | SitecoreApple iCloud MailMicrosoft 365+25 | Top 1M | 735 patents Multiplexed nucleic-acid biomarker assays for early cancer detection | — |
| 2 | Cellular Dynamics Human iPSC-derived cells and services for research, drug discovery, and therapy | $130M | 151 mo ago | — | James Thomson Founder | — | — | 520 patents Manufacturing and analytical technologies for advanced cell therapies and engineered immune cells | — |
| 3 | CereVasc Device for the treatment of patients with communicating hydrocephalus | $114M | 25 mo ago | 12 | Adel Malek Co-Founder | WordPressMySQLPHP+22 | Top 10M | 85 patents Neurovascular endovascular devices for subarachnoid access, hydrocephalus treatment, and drug delivery | — |
| 4 | Farcast Biosciences Developer of a system for preserving the tumor microenvironment | $85M | 95 mo ago | 24 24 → 48 (+100%) | Pradip Majumder Co-Founder | Wix eCommerceWixSentry+16 | Top 50M | — | — |
| 5 | Propeller Health Mobile platform and a sensor for respiratory health management | $64M | 96 mo ago | 119 | — | Apple iCloud MailSalesforce DeskSalesforce+7 | Top 50M | — | — |
| 6 | FUJIFILM Cellular Dynamics Provider of induced pluripotent stem cells for cell therapy | $62M | 163 mo ago | 150 | Takeshi Yamamoto Chairman & CEO | Cart FunctionalityMagentoWordPress+32 | Top 5M | 277 patents Manufacturing, purification, and dosing analytics for therapeutic cell and tissue products | — |
| 7 | NeuWave Medical Microwave ablation system for soft tissue and cancer ablation | $58M | 133 mo ago | 112 | Dan Van Der Weide Co-Founder | — | — | 250 patents Microwave ablation devices with temperature control and visualization for minimally invasive tissue treatment | — |
| 8 | Novelos Therapeutics Developer of drugs for the treatment and diagnosis of cancer | $54M | 148 mo ago | 25 | Jamey Weichert Founder | — | — | — | — |
| 9 | Elucent Medical Wireless Brease Marker for Breast Cancer Treatment | $50M | 26 mo ago | 11 | Laura King Co-Founder & CEO | — | — | — | — |
| 10 | Perceptive IO AI-powered automated robotic surgery device for dentists | $45M | 10 mo ago | — | Chris Ciriello Co-Founder & CEO | Craft CMSPHPYii+9 | Top 50M | 22 patents Vehicle safety and autonomous perception sensors integrating IR seat‑belt detection and centralized object detection networks. | — |
| 11 | Titan Spine Interbody fusion devices for spinal surgery | $42M | 91 mo ago | 98 | Peter Ullrich Co-Founder & CEO | — | — | 199 patents Patents concentrated in health & consumer products | — |
| 12 | FlexDex Developing a mechanical arm for MIS procedure | $40M | 30 mo ago | 10 | Thomas Davison Special Advisor to the CEO | — | — | 64 patents Advanced articulated handheld surgical and electrosurgical instruments with modular joint systems | — |
| 13 | Promentis Pharmaceuticals Developing innovative therapies for neuropsychiatric disorders, targeting glutamatergic imbalances | $36M | 77 mo ago | 4 | — | — | — | — | — |
| 14 | FluGen Developing innovative influenza vaccines with broad immune response and supra-seasonal protection | $34M | 58 mo ago | 12 | — | — | — | 136 patents Influenza vaccine design: mutant strains, immunogenic compositions, and thermostable formulations. | — |
| 15 | Imbed Biosciences Provider of nanotech-based wound care products 48Growth top 32%Funding top 37%Talent top 38%Moat top 39% All 7 signals ▾Growthtop 32% Fundingtop 37% Talenttop 38% Moattop 39% Techtop 44% Marketbottom 33% Globalbottom 32% Growth: Headcount 24 → 35 (+46%) across vintages · Fresh capital in last 24 mo Funding: Raised $34.3M across 18 rounds · 18 rounds over 16 yrs (1.1/yr) rank vs industry peers · Fliar Intelligence Index 48/100 | $34M | 4 mo ago | 35 35 → 40 (+14%) | Michael Schurr Co-Founder & Chief Medical Officer | WordPress Block EditorCart FunctionalityWordPress+30 | Top 50M | — | — |
| 16 | Rivermark Developer of medical device for treatment of benign prostatic hyperplasia | $34M | 1 mo ago | 5 | Andy Doraiswamy Co-Founder & Chairman | WebflowApple iCloud MailMicrosoft 365+9 | Top 50M | — | — |
| 17 | Scarab Genomics Developer of bioengineered E.coli strains for a range of applications | $26M | 21 mo ago | 16 | — | — | — | 148 patents Engineering reduced-genome microbes for high-yield recombinant protein production | — |
| 18 | DNASTAR Provider of software for genomics, structural biology, and clinical research | $22M | 13 mo ago | 41 41 → 26 (-37%) | — | WordPressMySQLRedis+44 | Top 5M | 7 patents Computational genomics and protein modeling software for sequence assembly and structure prediction | 3 launchs |
| 19 | Invenra Pioneering bispecific and trispecific antibody discovery and development for novel therapies | $21M | 92 mo ago | 97 97 → 57 (-41%) | — | — | — | 79 patents Engineering multispecific antibody constructs and heterodimerization platforms for therapeutic proteins. | — |
| 20 | TAI Diagnostics Provider of diagnostic solutions for transplant patients | $21M | 95 mo ago | 30 | — | — | — | — | — |
| 21 | EraGen Biosciences Molecular Reagent Products and molecular diagnostic products for early detection and monitoring of cancer… | $21M | 213 mo ago | 50 | — | — | — | 49 patents Patents concentrated in chemistry & materials | — |
| 22 | BioSentinel Innovative BoNT detection and potency testing solutions for biodefense and pharmaceutical applications | $21M | 176 mo ago | 16 | — | — | — | 14 patents FRET-based protease assays for botulinum toxin detection and related enzymatic screening | — |
| 23 | TomoTherapy Developer of radiation therapy system for the treatment of various types of cancers | $18M | 267 mo ago | 107 | Thomas Rock Co-Founder | — | — | 259 patents Patents concentrated in health & consumer products | — |
| 24 | Brainxell Neural stem cells and progenitor cells for life science research | $16M | 34 mo ago | 37 | Su Chun Zhang Founder | — | — | 8 patents Manufacturing stem‑cell derived dopaminergic and spinal GABAergic neuronal progenitors | 1 launch |
| 25 | NorthStar Medical Radioisotopes Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market | $15M | 13 mo ago | 305 | — | WordPressMySQLPHP+18 | Top 10M | — | 2 job openings · 1 partnership |
| 26 | InvivoSciences Precision medicine company personalizing drug development with 3D micro-tissue technology | $15M | 45 mo ago | 6 | — | — | — | 20 patents Automated 3D cardiac tissue and stem‑cell culture platforms for drug screening and therapy | — |
| 27 | Allergy Amulet Developer of a portable food allergen sensor for sample detection 42Moat top 31%Tech top 33%Growth top 35%Funding top 40% All 10 signals ▾Moattop 31% Techtop 33% Growthtop 35% Fundingtop 40% Producttop 46% Talentbottom 49% Innovationbottom 47% Patentsbottom 35% Globalbottom 31% Marketbottom 27% Moat: Editorial + unicorn rating 7/10 · IP moat: 11 patents Tech: 38 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 42/100 | $13M | 21 mo ago | 18 | Joseph BelBruno Co-Founder | Squarespace CommerceSquarespaceProton Mail+30 | Top 10M | 11 patents Electropolymerized biosensors for rapid food allergen detection and quantification. | — |
| 28 | GenoPalate Provider of personalized diet plans based on the genetic disposition 48Tech top 27%Talent top 28%Growth top 35%Funding top 40% All 9 signals ▾Techtop 27% Talenttop 28% Growthtop 35% Fundingtop 40% Productbottom 48% Customersbottom 40% Globalbottom 29% Marketbottom 24% Newsbottom 18% Tech: 67 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services Talent: Analyst team rating 4/5 rank vs industry peers · Fliar Intelligence Index 48/100 | $12M | 4 mo ago | 15 | — | Cart FunctionalityShopifySentry+57 | Top 5M | — | 1 partnership |
| 29 | Atterx Biotherapeutics Developing novel solutions to prevent and treat antibiotic-resistant bacterial infections | $12M | 122 mo ago | — | Steve Watt CEO | — | — | 8 patents Live bacterial therapeutics and small-colony variants for wound and surface healing | — |
| 30 | OnLume Developer of smart devices for fluorescence image-guided surgery | $12M | 41 mo ago | 26 | Andreas Velten Co-Founder | — | — | 6 patents Low-light video capture and multi-wavelength imaging technologies for dim environments | — |
| 31 | Stemina Biomarker Discovery Human in vitro toxicity testing for drug, food, and product safety | $11M | 120 mo ago | 14 | — | — | — | 78 patents Metabolomic biomarker assays for cardiotoxicity, developmental toxicity, and autism diagnostics | — |
| 32 | NovaScan Developer of diagnostic platform technology for cancer detection 32Innovation top 26%Patents top 26%Moat top 32%Funding top 36% All 8 signals ▾Innovationtop 26% Patentstop 26% Moattop 32% Fundingtop 36% Talentbottom 49% Globalbottom 40% Marketbottom 24% Techbottom 24% Innovation: 57 patents (top 28% of patent-holders) · 40 filings since 2022 vs 17 in 2017-21 Patents: 57 patents matched (strict assignee match) · 40 filings since 2022 vs 17 in 2017-21 rank vs industry peers · Fliar Intelligence Index 32/100 | $8M | 1 mo ago | 16 | Craig Davis President and CEO | WordPressMySQLPHP+11 | Top 50M | 57 patents Intraoperative cancer detection and tissue characterization via impedance-based medical devices | — |
| 33 | Gregor Diagnostics Provider of non-invasive screening test for prostate cancer | $7M | 8 mo ago | 12 | Steven Weinstein CEO | — | — | — | — |
| 34 | Platypus Technologies Provider of custom metal, optical, and patterned thin film coatings | $7M | 52 mo ago | 10 | — | WordPressMySQLPHP+22 | Top 5M | 88 patents UAV aerial imaging, surveillance, and data indexing; rock-climbing safety hardware solutions. | — |
| 35 | ReNeuroGen Developer of therapeutics to treat neutrophil-mediated diseases | $6M | 14 mo ago | 4 | Kirkwood Pritchard Co-Founder | — | — | 3 patents Chemico‑pharmacology platforms for drug discovery and therapeutic method development | — |
| 36 | PhylloTech Biotechnology company providing protein products for research use, including cytokines and other products | $6M | 12 mo ago | 2 | Colin Shepherd Co-Founder & COO | — | — | — | — |
| 37 | Stem Pharm Engineering human biology for neurologic drug discovery with advanced in vitro models | $6M | 6 mo ago | 10 | — | Cart FunctionalitySquarespace CommerceSquarespace+9 | Top 50M | — | — |
| 38 | AIQ Solutions AIQ Global: Optimizing late-stage cancer care with technology-enabled service | $6M | 3 mo ago | 25 25 → 21 (-16%) | Glenn Liu Co-Founder & Chief Medical Officer | WordPressMySQLPHP+18 | Top 50M | 22 patents Clinical decision-support tools for lesion monitoring and treatment side‑effect assessment | — |
| 39 | WiscMed Developer of an otoscope for an ear infection | $6M | 10 mo ago | — | James Berbee Co-Founder & Chairman & CEO | Cart FunctionalityShopifyVimeo+28 | Top 5M | — | — |
| 40 | Retham Technologies Developer of diagnosis and management of blood clotting disorder | $5M | 14 mo ago | 3 | — | — | — | — | — |
| 41 | Atrility Medical AI-powered cardiac monitoring for clearer decisions and improved patient care 24Innovation top 40%Funding top 43%AI top 45%Talent top 45% All 8 signals ▾Innovationtop 40% Fundingtop 43% AItop 45% Talenttop 45% Producttop 46% Techbottom 30% Globalbottom 29% Marketbottom 15% Innovation: 2 product lines Funding: Raised $3.4M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $3M | 7 mo ago | 8 | Nick Bergen Co-Founder | — | — | — | — |
| 42 | Neurosetta Provider of human stem cell-derived platform for high-throughput modeling of human brain and spinal cord… | $3M | 13 mo ago | — | Randolph Ashton Co-Founder & CEO | — | — | — | — |
| 43 | Proteovista Provider of bioinformatics services and DNA-binding assay development | $3M | 39 mo ago | 5 | Mary Ozers Co-Founder | — | — | 4 patents High-throughput SNP genotyping microarray technology for genetic analysis | — |
| 44 | Salus Discovery Molecular diagnostics innovator creating impactful solutions for real-world problems | $2M | 13 mo ago | 16 | Dave Beebe CEO & President | — | — | 56 patents Microfluidic bioseparation platforms for target isolation and stable interface chemistries. | — |
| 45 | Calimetrix Provides solution for magnetic resonance quantification | $2M | 36 mo ago | 7 | — | — | — | — | 2 awards |
| 46 | BellBrook Labs Specialty company engaged in drug discovery and biological research by providing screening solutions for… | $2M | 20 mo ago | 18 | Robert Lowery President & CEO | Cart FunctionalityWooCommerceWordPress+14 | Top 10M | 56 patents Small-molecule cGAS inhibitors for immunotherapy and inflammatory disease treatment | 1 launch |
| 47 | Cellular Logistics Acellular biomaterials for cardiac and tissue vascularization applications | $743K | 14 mo ago | 9 | Amish Raval Board Chairman and Founder | — | — | — | — |
| 48 | Estrigenix Developer of estrogen-based therapeutics women health | $598K | 17 mo ago | 4 | — | — | — | — | — |
| 49 | UP Oncolytics Developer of oncolytic and immunomodulatory therapies for cancer treatment | $500K | 8 mo ago | — | Parvez Akhtar Co-Founder | — | — | — | — |
| 50 | Geno.Me Online platform offering data mining tools for gene analysis | $400K | 13 mo ago | 6 | Britt Gottschalk Founder & CEO | — | — | 200 patents Medical nitric‑oxide generation, delivery devices, and diagnostic methods for cardiovascular therapy | — |
Top 12 Life Sciences companies in Wisconsin
#1
Series D · Milwaukee, Wisconsin · founded 2021 · 5 employees$34.2Mraised▾
Developer of medical device for treatment of benign prostatic hyperplasia. It offers minimally invasive device FloStent which consist of a nitinol stent that holds the prostatic urethra open to restore normal urinary function.
- May 2026Series D$20M
- Sep 2024Series C$30M
- Jul 2023Series A$4.1M
#2
Series C · Madison, Wisconsin · founded 2010 · 35 employees$34.3Mraised▾
Provider of nanotech-based wound care products. The company has developed technologies for embedding bioactive molecules in wound dressings and surgical implants. The products are based on the Microlyte Matrix technology platform. The company also offers antibacterial, anti-biofilm, and analgesic wound dressings.
- Jan 2026Series C—
- Jan 2024Convertible Debt$10M
- Dec 2023Series B$3.5M
- May 2023Series B$2.5M
#3
Series B · Milwaukee, Wisconsin · founded 2001 · 16 employees$8.1Mraised▾
Developer of diagnostic platform technology for cancer detection. The proprietary impedance-based platform technology for the detection of cancers. The company has developed a single impedance parameter that differs markedly between healthy and cancer tissue, called the Cole Relaxation Frequency.
- Nov 2021Series B$8M
- Sep 2020Seed$100K
- Jul 2017Seed$50K
- Jan 2011Grant (prize money)$1.1M
#4
Series A · Milwaukee, Wisconsin · founded 2016 · 15 employees$12.4Mraised▾
Provider of personalized diet plans based on the genetic disposition. The platform provides a DNA test kit for sample collection and analyses the sample using the proprietary algorithm to provide a report. The company provides insights into diet and food recommendations based on the results. A customized tool kit with nutritional information and advice is provided for consumers.
- Feb 2026Series A$250K
- Oct 2024Series A$3M
- Oct 2022Series A$5.6M
- Dec 2020Series A$4M
#5
Series A · Madison, Wisconsin · founded 2016 · 25 employees$5.5Mraised▾
AIQ Global: Optimizing late-stage cancer care with technology-enabled service. This is a technology company focused on improving treatment outcomes for late-stage cancer patients. They address a poorly served stage of the cancer patient journey by providing a software medical device, TRAQinform IQ, that offers novel information about the quantification of change in regions of interest over time. Oncologists/clinicians use this technology to more precisely adjust therapies and optimize clinical outcomes. The software integrates easily into existing workflows, utilizing serial radiographic images uploaded via the cloud to provide quantitative and spatial information. This enables oncologists to tailor treatment regimens and optimize outcomes based on a comprehensive report. The company is committed to innovation and clinical validation, aiming to change how clinicians manage complex diseases. This is a B2B SaaS company in the healthcare sector.
- Mar 2026Series A$1.4M
- Jul 2025Series A$1.6M
- May 2024Series A$2.3M
- Aug 2019Series A$3.2M
#6
Series B · Madison, Wisconsin · founded 2018$45.1Mraised▾
AI-powered automated robotic surgery device for dentists. The company combines novel imaging technology with AI and surgical robotics to automate surgery in dental industry.
- Aug 2025Grant (prize money)$1.7M
- Jul 2025Series B—
- Jul 2024Series B$30M
- Sep 2023Grant (prize money)$1.7M
#7
Funding Raised · Madison, Wisconsin · founded 2015 · 10 employees$5.9Mraised▾
Engineering human biology for neurologic drug discovery with advanced in vitro models. This company specializes in physiologically relevant human neural organoids featuring microglia for neuroimmune drug discovery. They offer comprehensive drug discovery services and partnerships, including neurologic disease modeling, target discovery, phenotypic drug screening, and neurotoxicity assessments. They also provide synthetic substrates, such as chemically-defined hydrogels and pre-coated cell culture plates, to improve outcomes for cell-based applications. Their team of experienced scientists designs and executes studies to generate new insights, supporting the movement to reduce animal testing in drug development. They focus on advancing research in areas like Alzheimer’s disease and neuroinflammatory diseases through innovative in vitro models.
- Dec 2025Grant (prize money)$406.5K
- Sep 2024Grant (prize money)$500K
- Sep 2023Grant (prize money)$554.9K
- Jul 2023Grant (prize money)$406.5K
#8
Series A · Madison, Wisconsin · founded 2016 · 12 employees$7.2Mraised▾
Provider of non-invasive screening test for prostate cancer. The company's proprietary assay analyzes seminal fluid for the presence of eight cancer-associated biomarkers that may be missed in blood or urine-based tests. The assay will stratify patients into no cancer, indolent cancer, and aggressive cancer levels. Patients can receive an at-home sample collection kit and send it to the company for analysis.
- Oct 2025Series A$242K
- Nov 2023Conventional Debt$6M
- Mar 2023Series A$7.4M
- Oct 2019Seed$915.7K
#9
Funding Raised · Madison, Wisconsin · founded 1984 · 41 employees$22Mraised▾
Provider of software for genomics, structural biology, and clinical research. The solutions include DNASTAR Lasergene Suite for genomics, structural biology, and molecular biology research, Molecular Biology Suite which can be used for multiple and pairwise sequence alignments, identify genes, assemble contigs of Sanger sequences, create clones, and other services.
- May 2025Grant (prize money)$6M
- Aug 2023Grant (prize money)$1.3M
- May 2020Grant (prize money)$5M
- Apr 2020Grant (prize money)$1.5M
#10
Series A · Madison, Wisconsin · founded 2017 · 8 employees$3.4Mraised▾
AI-powered cardiac monitoring for clearer decisions and improved patient care. This company is focused on transforming bedside monitoring through its innovative AtriRhythm AI platform and AtriAmp device. They provide solutions for critical care arrhythmia monitoring, addressing challenges in post-operative settings. Their technology facilitates continuous atrial electrogram monitoring, aiding in the diagnosis and treatment of atrial arrhythmias. The AI platform offers real-time component recognition, retrospective signal labeling, and literature-based interval mapping, providing clinicians with verifiable clinical insights. They are dedicated to improving cardiac health and patient outcomes through advances in medical technology, integrating healthcare, business, and engineering expertise. Their focus is on cardiac medical devices, atrial electrogram, arrhythmia monitoring, AI, and patient care.
- Nov 2025Series A$1M
- Sep 2024Grant (prize money)$275K
- Jun 2022Series A$3.4M
- Sep 2020Conventional Debt$300K
#11
Series B · Madison, Wisconsin · founded 2006 · 305 employees$15.1Mraised▾
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.
- May 2025Grant (prize money)$10.7M
- Jul 2019Grant (prize money)$15M
- Apr 2019Conventional Debt$75M
- Oct 2015Grant (prize money)$11.8M
#12
Series A · Middleton, Wisconsin · founded 2015$5.5Mraised▾
Developer of an otoscope for an ear infection. It provides views of the eardrum helping to make exams accurate. It also features an integrated LCD touchscreen, specula, and built-in nano camera. It helps in the diagnosis of an ear infection as it captures a photo of the eardrums.
- Jul 2025Series A$3M
- Nov 2022Series A$2M
- May 2020Series A$3.5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Wisconsin is moving
A read on the academic research around Biotechnology in Wisconsin — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 97 papers.
University of Wisconsin–Madison leads Wisconsin's biotechnology research, focusing optimistically on biofuel production, genetic mapping, and transcriptomics, with advancements outpacing concerns across 97 papers.
- University of Wisconsin–Madison72
- Medical College of Wisconsin9
- University of Wisconsin Carbone Cancer Center7
- University of Wisconsin–Milwaukee4
- University of Wisconsin–Extension3
- In vivo3
- Genome3
- Gene3
- Transcription factor2
- Flow cytometry2
- Selection (genetic algorithm)4
- Fermentation3
- Gene3
- Quantitative trait locus3
- Mesenchymal stem cell2
- Transcription (linguistics)2
- Metagenomics2
- Agriculture2
- Dairy cattle2
- Broiler1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.